In 2025, Category III codes 0913T and 0914T were introduced to streamline the reporting of percutaneous coronary interventions (PCI) by combining drug-coated balloon (DCB) angioplasty with advanced imaging techniques like intravascular ultrasound (IVUS) or optical coherence tomography (OCT). DCB angioplasty is a minimally invasive technique delivering antiproliferative drugs directly to narrowed or blocked arteries, promoting long-term vessel patency without permanent implants. These new codes reflect the growing role of innovative, precise therapies in coronary artery disease (CAD) management, ensuring accurate documentation and facilitating optimal reimbursement. Understanding key nuances is critical for correct and compliant coding come 2025. Let’s examine the details to score success now and throughout the new year.
Critical Understanding of Coronary Intervention via Drug Delivery Balloon
First, we need to understand what makes each code selection unique. Let’s start with Code 0913T. Code 0931T details PCI utilizing drug-eluting or drug-coated angioplasty and includes mechanical dilation with a non-drug delivery balloon and IVUS or OCT, when performed, on a major coronary artery or graft (left main, LAD, LCX, RCA, ramus intermedius) or a branch of the major coronary artery (LAD, LCX, RCA).
| 0913T | Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon (eg, drug-coated, drug-eluting), including mechanical dilation by nondrug-delivery balloon angioplasty, endoluminal imaging using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) when performed, imaging supervision, interpretation, and report, single major coronary artery or branch |
Code 0914T, however, is an add-on code. This code encompasses PCI utilizing drug-eluting or drug-coated angioplasty and includes mechanical dilation with a non-drug delivery balloon and IVUS or OCT, when performed. It is important to note this add-on code is reported when performed on a separate target lesion in addition to the primary intervention in the same major coronary artery or graft (left main, LAD, LCX, RCA, ramus intermedius) or a branch of the major coronary artery (LAD, LCX, RCA).
| +0914T | Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon (eg, drug-coated, drug-eluting) performed on a separate target lesion from the target lesion treated with balloon angioplasty, coronary stent placement or coronary atherectomy, including mechanical dilation by nondrug-delivery balloon angioplasty, endoluminal imaging using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) when performed, imaging supervision, interpretation, and report, single major coronary artery or branch (List separately in addition to code for percutaneous coronary stent or atherectomy intervention) |
For accurate coding, coders must hold a clear understanding of the procedure itself. Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-coated balloon (DCB) is a minimally invasive procedure used to treat coronary artery disease (CAD). It involves using a specialized balloon catheter to deliver antiproliferative drugs directly to the site of a narrowed or blocked coronary artery during percutaneous coronary interventions (PCI). This approach can be combined with other interventions aimed at restoring blood flow to the heart. DCBs provide long-term vessel patency and may offer comparable outcomes to drug-eluting stents (DES) without the need for permanent implants, making them a valuable option, particularly for in-stent restenosis cases.
With every dollar of reimbursement counting more than ever in the face of payment decline and complex new rules, it’s imperative to make sure your CPT® coding is correct and compliant. Master more cardiology coding topics and break down the complexity with our Cardiology All Access Pass. Find the right subscription and resource tailored to your needs today to make every member of your team successful with 2025 coding.
The 30th Annual Compliance Institute for the Health Care Compliance Association (HCCA) is scheduled to take place in Orlando next week. If you are there,
Sometimes you want to be contacted by the US Department of Health and Human Services (HHS) Office of Inspector General (OIG). I realize that
Please log in to your account to comment on this article.
Breast biopsy procedures may be clinically straightforward but accurately translating them into compliant billing can be anything but. In this focused webcast, Shawn Blackburn, CPC, CPMA, CIC, CRC, CCS-P breaks down how imaging guidance, lesion count, laterality, and payer expectations all impact how these procedures should be reported. Through clear explanations and real-world scenarios, you’ll gain practical insight into aligning clinical workflows with billing requirements, avoiding common pitfalls, and ensuring your documentation supports accurate reimbursement and compliance.
Gain clarity and confidence in OB‑GYN coding with this expert‑led webcast featuring Sherri L. Clayton, RHIT, CSS. You’ll learn how to apply global maternity package rules accurately, select the right CPT codes for procedures and visits, and identify documentation gaps that lead to denials. With practical guidance and real examples, this session helps you strengthen compliance, reduce audit risk, and ensure accurate reimbursement for women’s health services.
Uncover essential coding insights with nationally recognized coding authority Kay Piper, RHIA, CDIP, CCS. Through ICD10monitor’s interactive, on‑demand webcast series, Kay walks you through the AHA’s 2026 ICD‑10‑CM/PCS Quarterly Coding Clinics, translating each update into practical, easy‑to‑apply guidance designed to sharpen precision, ensure compliance, and strengthen day‑to‑day decision‑making. Available shortly after each official release.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s fourth quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Traditional utilization management models can no longer keep pace with regulatory shifts, payer scrutiny, and operational pressures. In this webcast, Tiffany Ferguson, LMSW, CMAC, ACM, ACPA-C, introduces an Adaptive Model strategy that modernizes UM through role specialization, technology-driven workflows, and proactive, team-based processes. Attendees will learn how to restructure programs to improve efficiency, strengthen clinical collaboration, and enhance financial performance in a rapidly changing healthcare environment.
Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
